The effect of dexamethasone on functional properties of HL60 cells during all-trans retinoic acid induced differentiation. Are there implications for the retinoic acid syndrome?

Blood Cells, Molecules, and Diseases

Volumn 22, Issue 2, 1996, Pages 139-149

  Sham, Ronald L ^a   Phatak, Pradyumna D ^a   Belanger, Kelly A ^a   Packman, Charles H ^b  

^a ROCHESTER GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

actin; acute promyelocytic leukemia; chemotaxis; glucocorticoids; interleukin 8; phagocytosis; retinoic acid

Indexed keywords

DEXAMETHASONE; F ACTIN; INTERLEUKIN 8; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; PHAGOCYTOSIS; PRIORITY JOURNAL;

ATRA;

EID: 0030221926     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1996.0021     Document Type: Article

References (33)

1. 1. Huang Meng-er, Ye Yu-chen, Chen Shu-rong, et al. Use of All-Trans Retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72(2):567-572, 1988.
2. 2. Castaigne S, Chomienne C, Daniel MT, et al. All-trans retinoic acid as differentiation therapy for acute promyelocytic leukemia. I.Clinical results. Blood 76:1704-1709, 1990.
3. 3. Warrell RP Jr, Frankel SR, Miller WH Jr et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all trans-retinoic acid). N Engl J Med 324:1385-1393, 1991.
4. 4. de The H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15:17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347:558-561, 1990.
5. 5. Sham RL, Phatak PD, Belanger KA, Braggins C, Packman CH. Functional characteristics of mature granulocytes in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid. Leuk Res 19(8):505-511, 1995.
6. 6. Glasser L, Fiederlein RL, Shamdas GJ, Brothman AR. Functional characteristics of in vivo induced neutrophils after differentiation therapy of acute promyelocytic leukemia with all-trans-retinoic acid. Cancer 73(4):1206-1212, 1994.
7. 7. Itoh Y, Ohyashiki K, Ohtaka M et al. All-trans-retinoic acid induced enrichment of functionally normal neutrophils in vivo in a patient with acute promyelocytic leukemia. Leukemia 6(8):806-808, 1992.
8. 8. Sham RL, Phatak PD, Belanger KA. Packman CH. Functional properties of HL60 cells matured with All-trans retinoic acid and DMSO: Differences in response to interleukin-8 and fMLP. Leuk Res 19(1): 1-6, 1995.
9. 9. Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 117:292-296, 1992.
10. 10. Collado-Escobar, D, Mollinedo F. Dexamethasone modifies the functional responses of the granulocytic differentiating HL-60 cells. Biochem J 299:533-559, 1994.
11. 11. Stone RM, Imamura K, Datta R, Sherman ML, Kufe DW. Inhibition of phorbol ester-induced monocytic differentiation and c-fms gene expression by dexamethasone: potential involvement of arachidonic acid metabolites. Blood 76(6): 1225-1232, 1990.
12. 12. Hoff T, Spencker T, Emmendoerffer A, Goppelt-Struebe M. Effects of glucocorticoids on the TPA-induced monocytic differentiation. J Leukoc Biol 52(2):173-182, 1992.
13. 13. Skubitz KM, Zhen Y, August JT. Dexamethasone synergistically induces chemotactic peptide receptor expression in HL-60 cells. Blood 59(3): 586-593, 1982.
14. 14. Petroni KC, Shen L, Guyre PM. Modulation of human polymorphonuclear leukocyte IgG Fc receptors-mediated functions by IFN-gamma and glucocorticoids. J Immunol 140(10):3467-3472, 1988.
15. 15. Meuleman J, Katz P. The immunologic effects, kinetics, and use of glucocorticoids. Med Clin North Am 69(4):805-816, 1985.
16. 16. Schleimer RP, Freeland HS, Peters SP, Brown KE, Derse CP. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharm Exp Ther 250(2):598-605, 1989.
17. 17. Paggiaro PL, Dente FL, Azzara A et al. Abnormal migratory activity of peripheral neutrophils from asthmatic patients and its modulation by inhaled glucocorticoids. J Invest Allergy Clin Immunol 3(5):237-244, 1993.
18. 18. Levine PH, Hardin JC, Scoon KL et al. Effect of corticosteroids on the production of superoxide and hydrogen peroxide and the appearance of chemiluminescence by phagocytosing polymorphonuclear leukocytes. Inflammation 5:19-27, 1981.
19. 19. Rinehart JJ, Balcerzale SP, Sagone AL et al. Effects of corticosteroids on human monocyte function. J Clin Invest 54:1337-1343, 1974.
20. 20. Dunn PA, Tyrer HW J. Quantitiation of neutrophil phagocytosis using fluorescent latex beads. Correlation of microscopy and flow cytometry. Lab Clin Med 98:374-381, 1981.
21. 21. Howard TH, Meyer WH. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J Cell Biol 98:1265-1271, 1984.
22. 22. Wallace PJ, Wersto RP, Packman CH, Lichtman, MA. Chemotactic peptide-induced changes in neutrophil actin conformation. J Cell Biol 99:1060-1065, 1984.
23. 23. Wilkinson PC. Micropore Filter Methods for Leukocyte Chemotaxis. Methods Enzymol 162:38-50, 1988.
24. 24. Blair OC, Carbone R, Sartorelli AC. Differentiation of HL-60 promyelocytic leukemia cells monitored by flow cy to metric measurement of Nitro Blue Tetrazolium (NBT) reduction. Cytometry 6:54-61, 1985.
25. 25. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 75:2458-2462, 1978.
26. 26. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL60) after induction of differentiation by dimethyl sulfoxide. J Exp Med 149:969-973, 1979.
27. 27. Breitman T, Selonick C, Collins S. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936-2940, 1980.
28. 28. Collins SJ. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiationa and cellular oncogene expression. Blood 70(5): 1233-1244, 1987.
29. 29. Niedel J, Kahane I, Lachman L, Cuatrecasas P. A subpopulation of cultured human promyelocytic leukemia cells (HL60) displays the formyl peptide chemotactic receptor. Proc Natl Acad Sci USA 77:1000-1004, 1980.
30. 30. Meyer WH, Howard TH. Changes in actin content during induced myeloid maturation of human promyelocytes. Blood 62:308-314, 1983.
31. 31. Meyer WH, Howard TH. Actin polymerization and its relationship to locomotion and chemokinetic response in maturing human promyelocytic leukemia cells. Blood 70:363-367, 1987.
32. 32. Sham RL, Packman CH, Abboud CN, Lichtman MA. Signal transduction and the regulation of actin conformation during myeloid maturation: studies in HL60 cells. Blood 77:363-370, 1991.
33. 33. Fontana JA, Wright DG, Schiffman E, Corcoran BA, Deisseroth AB. Development of chemotactic responsiveness in myeloid precursor cells: studies with a human leukemia cell line. Proc Natl Acad Sci 77:3664-3668, 1980.